New Solution Facilitating Brain Tumor Liquid Biopsies Gets FDA Breakthrough Device Designation
Cordance Medical’s device, NeuroAccess, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).
Read MorePosted by Andy Lundin | Oct 27, 2023 | Diagnostic Technologies |
Cordance Medical’s device, NeuroAccess, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).
Read MorePosted by Andy Lundin | Sep 28, 2023 | Disease States |
Anbio has developed an effective method using real-time polymerase chain reaction (RT-PCR) for the early detection of Parkinson’s Disease.
Read MorePosted by Andy Lundin | Sep 14, 2023 | Disease States |
AXIM’s assay uses a tiny teardrop to collect a fluid sample and can be run at a doctor’s office with results in less than 10 minutes.
Read MorePosted by Andy Lundin | Aug 30, 2023 | Disease States |
Researchers developed a test that detects Parkinson’s, potentially establishing a way to diagnose it before nervous system damage worsens.
Read MorePosted by Andy Lundin | Aug 23, 2023 | Dementias & Alzheimer’s |
Medical director Zaldy Tan, MD, MPH, answers questions about the Alzheimer’s blood test, as well as similar tests that are in development.
Read More